AIRS · Airsculpt Technologies, Inc.
Market Cap
$189.61M
Shares
72.10M
AIRS metrics
73 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$2.80
Market cap
$189.61M
Price action
19 metricsPrice change (1W)
+7.5%
Price change (30D)
-41.4%
Price change (3M)
-45.3%
Price change (6M)
+33.7%
Price change (YTD)
+41.2%
Price change (1Y)
-52.6%
Trailing year
Price change (5Y)
—
52-week high
$11.65
52-week low
$1.58
Change from 52-week high
-76.0%
Change from 52-week low
+76.9%
Annualized volatility
127.7%
Beta
2.9
RSI (14D)
41.2
Price vs SMA 50
-27.6%
Price vs SMA 200
-15.3%
Avg volume (3M)
712,222
Relative volume
2.2
Average dollar volume
$2.69M
Company
3 metricsSector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
72.10M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.4×
reciprocal yield 70.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
1.3×
reciprocal yield 79.5%
P / book
1.8
reciprocal yield 55.3%
FCF yield
0.4%
TTM · current market cap
Buyback yield
—
P / FCF
249.5
reciprocal yield 0.4%
P / operating cash flow
148.5
reciprocal yield 0.7%
Earnings yield
-6.2%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.0×
reciprocal yield 50.1%
EV / revenue historical average (5Y)
2.0×
reciprocal yield 50.3%
EV / EBIT historical average (3Y)
83.0×
reciprocal yield 1.2%
EV / EBIT historical average (5Y)
83.0×
reciprocal yield 1.2%
EV / EBITDA historical average (3Y)
86.1×
reciprocal yield 1.2%
EV / EBITDA historical average (5Y)
86.6×
reciprocal yield 1.2%
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
2022-08-25
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-10
Profitability
9 metricsGross margin
—
Operating margin
-8.4%
Trailing 12 months
Net margin
-7.8%
Gross profit (TTM)
—
Operating profit (TTM)
−$12.59M
Net income (TTM)
−$11.74M
Trailing 12 months
Diluted EPS (TTM)
$-0.18
FCF margin
0.5%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-2.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$150.72M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+18.8%
Year over year · more shares
Revenue CAGR (3Y)
-3.5%
Revenue CAGR (5Y)
+19.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-60.8%
FCF CAGR (5Y)
-41.7%
Quality
14 metricsReturn on equity
-11.2%
Return on assets
-6.1%
Debt / equity
0.4
Current ratio
0.8
EBITDA (TTM)
−$333,000
Free cash flow (TTM)
$760,000
Quick ratio
0.8
Interest coverage
-2.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$24.74M
Latest balance sheet
Cash & equivalents
$18.82M
Total assets
$193.28M
Total debt
$43.57M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$1.28M
Capital expenditures (TTM)
$517,000
R&D (TTM)
—
SG&A (TTM)
$83.74M
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
104
13F filer change QoQ
+14
Institutional ownership
64.0%
Short interest
3 metricsShort interest
3.9%
Latest settlement · 2.3 days to cover
Days to cover
2.3d
Short-squeeze score
43 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1870940
CUSIP
009496100
13F (30d)
85 filings
85 filers
Visit website
Investor relations